Skip to main content
Top
Published in: Diabetology International 3/2019

01-07-2019 | Original Article

The association between glycemic control and lung function impairment in individuals with diabetes: the Saku study

Authors: Nao Sonoda, Akiko Morimoto, Yukako Tatsumi, Kei Asayama, Takayoshi Ohkubo, Satoshi Izawa, Yuko Ohno

Published in: Diabetology International | Issue 3/2019

Login to get access

Abstract

Aim

Though diabetes is a risk factor for lung function impairment, whether the glycemic control level affects lung function in individuals with diabetes remains unclear. The present study aimed to assess the association between glycemic control level and restrictive or obstructive lung function impairment in individuals with diabetes.

Methods

This cross-sectional study included 1028 individuals with diabetes, aged 40–69 years, who underwent a medical checkup between April 2008 and March 2014. Hemoglobin A1c (HbA1c) was categorized as  < 6.9%, 7.0–7.9%, and  ≥ 8.0%. Restrictive and obstructive lung function impairment was defined by a forced vital capacity (FVC) < 80% predicted and a forced expiratory volume in 1 s to FVC ratio < 0.70.

Results

Of the participants, 8.7% and 6.3% were classified as having restrictive and obstructive lung function impairment, respectively. The multivariable-adjusted odds ratios and 95% confidence intervals for restrictive lung function impairment were 1.43 (0.84–2.42) in individuals with HbA1c 7.0–7.9%, and 2.42 (1.38–4.26) in individuals with HbA1c ≥ 8.0%, compared with those who had HbA1c < 6.9% (p for trend = 0.002). In contrast, glycemic control level was not associated with obstructive lung function impairment (p for trend = 0.749).

Conclusions

Poor glycemic control was associated with restrictive lung function impairment in individuals with diabetes. Good glycemic control would be important to minimize restrictive lung function impairment in individuals with diabetes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Yokomichi H, Nagai A, Hirata M, Kiyohara Y, Muto K, Ninomiya T, BioBank Japan Cooperative Hospital Group, Yamagata Z, et al. Survival of macrovascular disease, chronic kidney disease, chronic respiratory disease, cancer and smoking in patients with type 2 diabetes: BioBank Japan cohort. J Epidemiol. 2017;27:S98–106.CrossRefPubMedPubMedCentral Yokomichi H, Nagai A, Hirata M, Kiyohara Y, Muto K, Ninomiya T, BioBank Japan Cooperative Hospital Group, Yamagata Z, et al. Survival of macrovascular disease, chronic kidney disease, chronic respiratory disease, cancer and smoking in patients with type 2 diabetes: BioBank Japan cohort. J Epidemiol. 2017;27:S98–106.CrossRefPubMedPubMedCentral
2.
go back to reference Van den Borst B, Gosker HR, Zeegers MP, Schols AM. Pulmonary function in diabetes: a metaanalysis. Chest. 2010;138:393–406.CrossRefPubMed Van den Borst B, Gosker HR, Zeegers MP, Schols AM. Pulmonary function in diabetes: a metaanalysis. Chest. 2010;138:393–406.CrossRefPubMed
3.
go back to reference Sonoda N, Morimoto A, Tatsumi Y, Asayama K, Ohkubo T, Izawa S, et al. A prospective study of the impact of diabetes mellitus on restrictive and obstructive lung function impairment: the Saku study. Metabolism. 2018;82:56–64.CrossRef Sonoda N, Morimoto A, Tatsumi Y, Asayama K, Ohkubo T, Izawa S, et al. A prospective study of the impact of diabetes mellitus on restrictive and obstructive lung function impairment: the Saku study. Metabolism. 2018;82:56–64.CrossRef
4.
go back to reference Morimoto A, Tatsumi Y, Deura K, Mizuno S, Ohno Y, Miyamatsu N, et al. Impact of impaired insulin secretion and insulin resistance on the incidence of type 2 diabetes mellitus in a Japanese population: the Saku Study. Diabetologia. 2013;56:1671–9.CrossRefPubMed Morimoto A, Tatsumi Y, Deura K, Mizuno S, Ohno Y, Miyamatsu N, et al. Impact of impaired insulin secretion and insulin resistance on the incidence of type 2 diabetes mellitus in a Japanese population: the Saku Study. Diabetologia. 2013;56:1671–9.CrossRefPubMed
5.
go back to reference Tatsumi Y, Morimoto A, Miyamatsu N, Noda M, Ohno Y, Deura K. Effect of body mass index on insulin secretion or sensitivity and diabetes. Am J Prev Med. 2015;48:128–35.CrossRefPubMed Tatsumi Y, Morimoto A, Miyamatsu N, Noda M, Ohno Y, Deura K. Effect of body mass index on insulin secretion or sensitivity and diabetes. Am J Prev Med. 2015;48:128–35.CrossRefPubMed
6.
go back to reference Kashiwagi A, Kasuga M, Araki E, et al. Committee on the standardization of diabetes mellitus-related laboratory testing of Japan Diabetes Society. International clinical harmonization of glycated hemoglobin in Japan: from Japan diabetes society to national glycohemoglobin standardization program values. J Diabetes Invest. 2012;3:39–40.CrossRef Kashiwagi A, Kasuga M, Araki E, et al. Committee on the standardization of diabetes mellitus-related laboratory testing of Japan Diabetes Society. International clinical harmonization of glycated hemoglobin in Japan: from Japan diabetes society to national glycohemoglobin standardization program values. J Diabetes Invest. 2012;3:39–40.CrossRef
7.
go back to reference Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res. 2014;37:253–390.CrossRefPubMed Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res. 2014;37:253–390.CrossRefPubMed
8.
go back to reference Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, et al. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan-2012 version. J Atheroscler Thromb. 2013;20:517–23.CrossRefPubMed Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, et al. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan-2012 version. J Atheroscler Thromb. 2013;20:517–23.CrossRefPubMed
9.
go back to reference American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995;152:1107–36.CrossRef American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995;152:1107–36.CrossRef
10.
go back to reference Kubota M, Kobayashi H, Quanjer PH, Omori H, Tatsumi K, Kanazawa M, Clinical Pulmonary Functions Committee of the Japanese Respiratory Society. Reference values for spirometry, including vital capacity, in Japanese adults calculated with the LMS method and compared with previous values. Respir Investig. 2014;52:242–50.CrossRefPubMed Kubota M, Kobayashi H, Quanjer PH, Omori H, Tatsumi K, Kanazawa M, Clinical Pulmonary Functions Committee of the Japanese Respiratory Society. Reference values for spirometry, including vital capacity, in Japanese adults calculated with the LMS method and compared with previous values. Respir Investig. 2014;52:242–50.CrossRefPubMed
11.
go back to reference Scarlata S, Fimognari FL, Cesari M, et al. Lung function changes in older people with metabolic syndrome and diabetes. Geriatr Gerontol Int. 2013;13:894–900.CrossRefPubMed Scarlata S, Fimognari FL, Cesari M, et al. Lung function changes in older people with metabolic syndrome and diabetes. Geriatr Gerontol Int. 2013;13:894–900.CrossRefPubMed
12.
go back to reference Ford ES, Cunningham TJ, Mercado CI. Lung function and metabolic syndrome: findings of National Health and Nutrition Examination Survey 2007–2010. J Diabetes. 2014;6:603–13.CrossRefPubMedPubMedCentral Ford ES, Cunningham TJ, Mercado CI. Lung function and metabolic syndrome: findings of National Health and Nutrition Examination Survey 2007–2010. J Diabetes. 2014;6:603–13.CrossRefPubMedPubMedCentral
13.
go back to reference Wanke T, Formanek D, Auinger M, Popp W, Zwick H, Irsigler K. Inspiratory muscle performance and pulmonary function changes in insulin-dependent diabetes mellitus. Am Rev Respir Dis. 1991;143:97–100.CrossRefPubMed Wanke T, Formanek D, Auinger M, Popp W, Zwick H, Irsigler K. Inspiratory muscle performance and pulmonary function changes in insulin-dependent diabetes mellitus. Am Rev Respir Dis. 1991;143:97–100.CrossRefPubMed
14.
go back to reference Meo SA, Al-Drees AM, Arif M, Shah FA, Al-Rubean K. Assessment of respiratory muscles endurance in diabetic patients. Saudi Med J. 2006;27:223–6.PubMed Meo SA, Al-Drees AM, Arif M, Shah FA, Al-Rubean K. Assessment of respiratory muscles endurance in diabetic patients. Saudi Med J. 2006;27:223–6.PubMed
15.
go back to reference Fuso L, Pitocco D, Longobardi A, Zaccardi F, Contu C, Pozzuto C, et al. Reduced respiratory muscle strength and endurance in type 2 diabetes mellitus. Diabetes Metab Res Rev. 2012;28:370–5.CrossRefPubMed Fuso L, Pitocco D, Longobardi A, Zaccardi F, Contu C, Pozzuto C, et al. Reduced respiratory muscle strength and endurance in type 2 diabetes mellitus. Diabetes Metab Res Rev. 2012;28:370–5.CrossRefPubMed
Metadata
Title
The association between glycemic control and lung function impairment in individuals with diabetes: the Saku study
Authors
Nao Sonoda
Akiko Morimoto
Yukako Tatsumi
Kei Asayama
Takayoshi Ohkubo
Satoshi Izawa
Yuko Ohno
Publication date
01-07-2019
Publisher
Springer Japan
Published in
Diabetology International / Issue 3/2019
Print ISSN: 2190-1678
Electronic ISSN: 2190-1686
DOI
https://doi.org/10.1007/s13340-018-0382-y

Other articles of this Issue 3/2019

Diabetology International 3/2019 Go to the issue